TD Has Lowered Expectations for Vitalhub (TSE:VHI) Stock Price

Vitalhub (TSE:VHI – Get Free Report) had its target price reduced by equities research analysts at TD from C$13.00 to C$9.50 in a report released on Monday, BayStreet reports. The firm presently has a “buy” rating on the stock. TD‘s price target would indicate a potential upside of 45.71% from the company’s current price.

VHI has been the subject of several other research reports. Canaccord Genuity Group set a C$15.00 price target on Vitalhub and gave the stock a “buy” rating in a research note on Friday, August 28th. ATB Cormark Capital Markets cut their price objective on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating on the stock in a research note on Monday. Nine analysts have rated the stock with a Buy rating. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of C$10.86.

View Our Latest Research Report on Vitalhub

Vitalhub Price Performance

VHI stock traded down C$0.48 on Monday, reaching C$6.52. The company’s stock had a trading volume of 481,442 shares, compared to its average volume of 297,780. Vitalhub has a 52 week low of C$6.46 and a 52 week high of C$9.77. The company has a market capitalization of C$412.97 million, a P/E ratio of 54.33, a price-to-earnings-growth ratio of 1.18 and a beta of 1.37. The firm has a fifty day moving average of C$7.56 and a two-hundred day moving average of C$7.58.

Vitalhub (TSE:VHI – Get Free Report) last announced its earnings results on Thursday, November 12th. The company reported C$0.04 earnings per share for the quarter. The firm had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. As a group, equities analysts expect that Vitalhub will post 0.23 EPS for the current fiscal year.

Vitalhub Company Profile

(Get Free Report)

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.

See Also

Analyst Recommendations for Vitalhub (TSE:VHI)

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.